To what extend is nail ultrasound discriminative between psoriasis, psoriatic arthritis and healthy subjects?
Sign Up to like & getrecommendations! Published in 2018 at "Rheumatology International"
DOI: 10.1007/s00296-018-4222-y
Abstract: To assess the discriminative utility of nail features detected by B-mode (BM) and color Doppler (CD) ultrasound (US) between patients with psoriasis (PsO) and psoriatic arthritis (PsA) and healthy controls. Sixty patients with PsA, 21… read more here.
Keywords: psoriatic arthritis; psa; nail bed; nail ... See more keywords
Long-Term Safety of Ixekizumab Treatment in Patients with Psoriasis, Psoriatic Arthritis, or Axial Spondyloarthritis: a Post Hoc Analysis of Cerebro-Cardiovascular Events
Sign Up to like & getrecommendations! Published in 2025 at "Dermatology and Therapy"
DOI: 10.1007/s13555-024-01323-9
Abstract: Psoriasis (PsO), psoriatic arthritis (PsA), and axial spondyloarthritis (axSpA) may confer an increased risk for cardiovascular (CV) disease, including major adverse cerebro-cardiovascular events (MACE), deep vein thrombosis (DVT), and pulmonary embolism (PE). Patients with these… read more here.
Keywords: psa axspa; 100 pso; pso psa;
Real-world registry-based study on apremilast use in psoriasis and psoriatic arthritis in Finland.
Sign Up to like & getrecommendations! Published in 2023 at "Scandinavian journal of rheumatology"
DOI: 10.1080/03009742.2022.2151109
Abstract: OBJECTIVES This study assessed the position of apremilast in the treatment pathway of psoriasis (PsO) and psoriatic arthritis (PsA) in Finnish clinical practice, compared the characteristics of apremilast and biologic therapy users, evaluated persistence with… read more here.
Keywords: persistence; pso psa; apremilast; psoriatic arthritis ... See more keywords
The association between biologic agents and the risk of cardiovascular events in patients with psoriasis and psoriatic arthritis
Sign Up to like & getrecommendations! Published in 2019 at "Medicine"
DOI: 10.1097/md.0000000000018063
Abstract: Abstract Background: Psoriasis (Pso) is a chronic, recurrent, and inflammatory disease involving genetic and immune factors. Psoriatic arthritis (PsA), accounting for 30% of Pso, is an inflammatory arthropathy. Pso and PsA are associated with increased… read more here.
Keywords: cardiovascular events; pso psa; agents risk; psoriatic arthritis ... See more keywords
FRI0699-HPR DEVELOPMENT OF DELPHI-BASED RECOMMENDATIONS FOR THE MANAGEMENT OF CARDIOVASCULAR COMORBIDITIES IN PATIENTS WITH PSORIATIC ARTHRITIS AND MODERATE-TO-SEVERE PSORIASIS: STUDY PROTOCOL
Sign Up to like & getrecommendations! Published in 2019 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2019-eular.6988
Abstract: Background Psoriasis (PSO) and Psoriatic Arthritis, (PsA) particularly moderate to severe disease (MS-PSO), are inflammatory systemic conditions that are associated with a high risk of cardiovascular (CV) complications further beyond the increased prevalence of classical… read more here.
Keywords: none declared; pfizer; management; delphi ... See more keywords